Loading…
avatar for Sheldon Preskorn, MD

Sheldon Preskorn, MD

President and Chief Executive Officer, Clinical Research Institute; Professor, Department of Psychiatry. University of Kansas School of Medicine, Wichita, Kansas

Sheldon H. Preskorn, M.D., is Professor in the Department of Psychiatry at the University of Kansas School of Medicine-Wichita (KUSM-W) and Chief Science Officer for KUSM-W Clinical Trials Unit. and Professor of Psychiatry at the Laureate Institute for Brain Research.

A fellow of the American Psychiatric Association and the American Psychopathological Association, Dr. Preskorn has served on advisory committees of the U.S. Food and Drug Administration, Veterans Administration, National Institutes of Health and National Science Foundation, and was a consultant to the Menninger Foundation on clinical psychopharmacology.

Dr. Preskorn received his Medical Degree at the University of Kansas, Kansas City, Kansas.  He completed a two-year residency in anatomical pathology (with emphasis on neuropathology) and a one-year rotating internship in internal medicine and psychiatry at the University of Kansas Medical Center, Kansas City, Kansas and his residency in psychiatry at Washington University School of Medicine, St. Louis, Missouri.  He has undergraduate degree in psychobiology (psychology, biology and chemistry) and postgraduate medical training in anatomical pathology (neuropathology), psychiatry, and basic and clinical pharmacology.

Dr. Preskorn is an international lecturer and the author of 500 scientific, professional articles, and books. He has received continuous grant funding since 1978 for an estimated life-time total of $150 million. This funding has allowed him to pursue research in psychopharmacology and neuroscience of psychiatric illnesses.

Dr. Preskorn’s basic pharmacological and neuroscience research has included studies in learning theory, neurochemistry, neurophysiology, histochemistry, electron microscopy, cerebral blood flow and metabolism, positron emission tomography and radioligand binding. His clinical research has included pharmacokinetics, drug-drug interactions, and drug development through all clinical phases from “first time in man” studies through phase III trials. Dr. Preskorn has been the Principal Investigator on over 350 clinical trials including drug development studies of all antidepressants and antipsychotics marketed in the United States in the last 25 years.  He also has extensive experience with the drug registration process having been involved in the registration process for 8 of the 12 antidepressants marketed in the United States over the last 25 years and the only implantable device approved for the treatment of a psychiatric illness.

In addition to this research work, Dr. Preskorn’s clinical and administrative experience includes six years as supervising physician for an acute psychosis ward, six years as chief of psychiatry for a university affiliated Veterans Administration Medical Center, five years as director of the KUSM-W Outpatient Psychiatric Clinic and eight years as Chair of the KUSM-W Department of Psychiatry.

Dr. Preskorn was the founding President and Medical Director of the Psychiatric Research Institute, an affiliate of Via-Christi Regional Medical Center from 1988-2003 and President and Medical Director of the Clinical Research Institute from 2003-2010.